Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 0 | 0 | 2,006 | 34 | 28 |
| Gross Profit | N/A | 0 | 2,006 | 34 | 28 |
| Operating Expenses | 35,860 | 28,275 | 21,395 | 26,747 | 24,883 |
| Operating Income | -35,860 | -28,275 | -19,389 | -26,713 | -24,855 |
| Other Income | 1,953 | 1,392 | 1,884 | 1,293 | 553 |
| Pre-tax Income | -33,907 | -26,883 | -17,505 | -25,420 | -24,302 |
| Income Tax | -237 | 1,296 | -253 | -245 | -11 |
| Net Income Continuous | -33,670 | -28,179 | -17,252 | -25,175 | -24,291 |
| Net Income | $-33,670 | $-28,179 | $-17,252 | $-25,175 | $-24,291 |
| EPS Basic Total Ops | -0.40 | -0.37 | -0.25 | -0.38 | -0.45 |
| EPS Basic Continuous Ops | -0.40 | -0.36 | -0.25 | -0.38 | -0.45 |
| EPS Diluted Total Ops | -0.40 | -0.37 | -0.25 | -0.38 | -0.45 |
| EPS Diluted Continuous Ops | -0.40 | -0.36 | -0.25 | -0.38 | -0.45 |
| EPS Diluted Before Non-Recurring Items | -0.40 | -0.39 | -0.25 | -0.38 | -0.45 |
| EBITDA(a) | $-35,499 | $-27,914 | $-19,015 | $-26,376 | $-24,582 |